Find Your MAC! Add TransLabs as a preferred
source on Google
Arkansas HB 1297 AI Legislation

Arkansas HB 1297 AI Legislation: How AI-in-Billing Disclosure Proposition Impacts Lab Revenue Cycle Systems in 2026

Arkansas HB 1297 never became law. It was withdrawn in April 2025, but its ripple effects are still being felt in lab billing circles today. The bill would have barred insurers from using AI as the sole reason for denying, delaying, or downgrading claims, and it would have given the state insurance commissioner real enforcement power. Without it, commercial payers in Arkansas aren’t bound by any state-level AI transparency rule for private claims.

That said, Arkansas did pass Act 848, which requires human oversight for AI decisions made by public entities, including state Medicaid operations. So while private insurers remain unregulated on this front, Medicaid claims have some protection.

Meanwhile, other states like Iowa, Washington, and Alabama have already enacted their own AI prior authorization laws. If your lab bills patients outside Arkansas, those rules still apply to those claims. The smartest move right now? Strengthen documentation, track denial patterns closely, and treat every appeal like the algorithm behind it needs to be proven wrong.

Quick question for you: if an insurer’s algorithm denies your lab’s claim in just three seconds flat, who’s actually accountable for that call? Right now, in most states, the honest answer is “nobody in particular.” That’s the exact problem Arkansas lawmakers tried to fix in 2025, and even though their bill never made it into law, its effects are all over the billing landscape labs are dealing with in 2026.

If you run a lab, manage pathology billing, or handle revenue cycle work for a diagnostics company, this one’s for you. We’re breaking down what Arkansas HB 1297 proposed, why it got pulled, and what it means for your claims, your appeals, and laboratory billing services in Arkansas going forward.

Get Reimbursed Fast and in Full For Your Arkansas Laboratory Claims.

Arkansas HB 1297 AI Legislation: The Bill That Almost Changed the Rules

Arkansas House Bill 1297, filed by Representative Lee Johnson and Senator Missy Irvin, landed in the state legislature on January 29, 2025, as a bill concerning artificial intelligence, algorithms, and other automated technologies, aimed at regulating certain practices of healthcare payers. It moved through committee, picked up an amendment in late February, and then just stopped. The House withdrew it on April 1, 2025.

So no, HB 1297 isn’t a law you can cite in an appeal letter today. But that doesn’t mean it doesn’t matter at all. Think of it like a trial. It presented an idea, showed lawmakers (and the insurance industry) what real AI oversight could look like, and set the tone for a wave of similar bills that have since passed in other states.

What Would HB 1297 Have Actually Required?

Here’s the part most billing teams never got to see in action. Had it passed, HB 1297 would have prohibited insurers from using AI as the sole basis for denying, delaying, or modifying healthcare services. It also would have handed real command to the Arkansas Insurance Commissioner, including audit authority and the power to fine insurers up to $25,000 per violation.
Proposed RequirementWhat It Meant for PayersWhy Labs Cared
No AI-only denialsA human had to sign off before a claim could be denied, delayed, or downgradedFewer bulk denials on molecular and toxicology panels
Algorithm disclosureInsurers had to reveal how their AI models worked and their known limitsLabs could actually see the logic behind a denial, not just get a form letter
Commissioner oversightAudits and fines up to $25,000 per violationReal financial consequences for careless AI use

Why Did HB 1297 Get Pulled?

HB 1297 was withdrawn by its author on April 1, 2025, before it reached a full floor vote, so it never became binding law in Arkansas. If you’re wondering what led to that, there isn’t a publicly known single reason for it. In general, such bills get withdrawn for multiple reasons: pushback from industry lobbyists, funding concerns, a sponsor deciding to fold the idea into a different vehicle, or simply running out of legislative runway before the session ends. What we do know is that Arkansas didn’t drop the subject of AI regulation altogether. In fact, it acted quite the opposite.

Act 848: The AI Law That Actually Passed in Arkansas

Arkansas did pass an AI oversight law in 2025, but it’s not a healthcare insurance law. House Bill 1958, signed by Governor Sarah Huckabee Sanders on April 17, 2025, became Act 848. It applies to public entities, meaning state agencies, public schools, and local governments, not private insurance carriers. The law requires those public entities to create formal policies governing AI and automated decision tools, with a human reviewer always making the final call.

That’s an important distinction. Act 848 won’t stop a commercial payer or a Medicaid managed care organization from leaning on AI to review your lab claims. It’s a government-operations law, not a private insurance law. If your lab bills Arkansas Medicaid directly, though, the human-oversight principle behind Act 848 is worth knowing, since state Medicaid operations do fall under its umbrella.

This law passed with huge support in the Arkansas legislature. It’s a sign that lawmakers agree AI shouldn’t make final calls without a human checking its work.

Let’s look at it at a glance:

  • Signed: April 17, 2025
  • Effective: August 3, 2025
  • Applies to: Arkansas public entities, including state agencies and Medicaid operations
  • Core rule: A human must make the final decision, even when AI generates the recommendation

How Does HB 1297 Still Shape Lab Billing and RCM in Arkansas?

HB 1297 died, and Act 848 only covers government entities. Does that mean lab billing teams in Arkansas have nothing to lean on? Not quite. Here’s the practical reality heading into the back half of 2026.

Commercial Payers Still Aren't Bound by a Statewide AI Denial Law

Without a passed version of HB 1297, Arkansas labs dealing with commercial insurers don’t have a hard state law forcing AI transparency on private claim denials. That’s frustrating, but it’s also exactly why documentation discipline becomes more important. If a payer can’t or won’t explain why an algorithm flagged your NGS panel or toxicology screen, that gap is your leverage in an appeal, even without a statute backing you up.

National Momentum Is Doing What HB 1297 Couldn't

Here’s an interesting fact. Something that Arkansas started and didn’t finish, other states are running with. As of early 2026, more than 25 states had issued guidance based on the National Association of Insurance Commissioners’ 2023 model bulletin, which sets expectations that AI-assisted insurance decisions still comply with existing anti-discrimination and unfair-practice laws.

A handful of states have gone further and passed hard prior authorization rules that lab billing teams everywhere should watch:

StateLawKey Rule
IowaHF 2635AI can't be the sole basis for a denial, delay, or downgrade of a medical necessity request; a qualified reviewer or clinical peer must sign off
WashingtonSB 5395Only a licensed physician or health professional can deny a prior authorization based on medical necessity
AlabamaSB 63AI-driven prior authorization decisions must rely on the patient's own medical history, not group datasets
IndianaHB 1271Bans AI as the sole basis for downcoding a claim without a clinician reviewing the record
UtahSB 319Insurers must publicly disclose whether AI is used to review prior authorization requests, effective January 1, 2027
Does any of this apply if my lab bills patients outside Arkansas? Yes, and that’s the point. If your lab or reference lab network handles specimens from patients covered by Iowa, Washington, Alabama, or Indiana plans, those states’ AI rules apply to that claim, regardless of where your lab is physically located.

What are the Important Denial Patterns to Track for Arkansas Labs?

Whether or not a state has a hard AI law on the books, one thing hasn’t changed: bulk denials on high-volume and low-margin lab tests are a real drain on cash flow. Molecular diagnostics, toxicology screens, and genetic panels get caught a lot in algorithmic dragnet more than routine chemistry panels do, simply because they’re higher-cost and easier for an algorithm to flag.

This becomes easier when you use denial management services to track denial reasons and patterns and make it a proactive, rather than reactive, process for future claims.

How Should Your Arkansas Lab Act Right Now?

Here’s what a smart RCM strategy looks like for 2026, with or without HB 1297 on the books.

Audit your own RCM vendor's AI use

If your billing partner uses automated coding, claim scrubbing, or predictive analytics, ask how those tools are validated and whether a human reviews flagged claims before submission.

Document everything on complex tests

Genetic panels, NGS, and definitive drug testing need clear clinical justification attached at submission with complete documents. These shouldn’t be added later during an appeal.

Track denial reason codes by payer

If one payer’s denial rate spikes on a specific CPT code, that’s a pattern worth escalating, not just re-billing one claim at a time.

Ask payers for their review criteria

You’re allowed to request the clinical guidelines behind a denial. Make it standard practice, not a last resort.

Watch multi-state exposure

If your lab serves patients across state lines, map which of those states already have AI prior authorization laws so your team knows which claims have extra legal backing.

Outsource your Arkansas lab billing

All of the above actions are important for laboratories across Arkansas to get paid fully and protect their revenue. But when you’re busy performing tests and managing other aspects of your day-to-day lab operations, doing that all isn’t an easy task.

Solution? Partner with a dedicated Arkansas billing company, like TransLabs, that provides comprehensive laboratory RCM solutions, helping manage all these RCM aspects. The best part is you don’t need to hire billers for the task. They have a dedicated staff of billing experts who are well-versed in all the ins and outs of the billing landscape across The Wonder State.

They help with payer compliance and make sure to review AI-automated claim denials, fight them through well-documented appeals, and get your laboratory paid every dollar you deserve.

Prevent AI-Automated Claim Denials with Dedicated Billing Expertise and Appeal Management.

Conclusion

Arkansas HB 1297 never made it to the governor’s desk, but it didn’t disappear for nothing either. It paved the way for a revolution in the billing industry, finding its way into statehouses across the country. But it left Arkansas labs in an in-between spot: no dedicated state law on private AI denials, but a national trend that’s building real leverage for providers everywhere. The smartest move for your lab isn’t waiting on Little Rock to try again. It’s tightening your own documentation, watching your denial patterns actively, and outsourcing billing to an RCM partner that maintains the same transparency standard you’d want from any payer.

Frequently Asked Questions

Did Arkansas HB 1297 ever become law?

HB 1297 was introduced on January 29, 2025, and withdrawn by its author on April 1, 2025, before receiving a full vote.
Act 848 (originally HB 1958) governs how Arkansas public entities and government agencies use AI. HB 1297 targeted private health insurers specifically, and that bill never passed.
Arkansas has not enacted a private-insurance AI denial law so far, unlike states such as Iowa, Washington, and Alabama.
You can request the clinical criteria behind any denial and build your appeal around documented medical necessity, regardless of whether a specific AI statute applies.
Given the national trend and the unanimous support Act 848 received, similar legislation targeting private insurers could resurface in a future session in Arkansas, though nothing is currently scheduled.
Bulk denials on high-cost, low-margin tests like molecular diagnostics and toxicology panels are the biggest risks in AI-driven billing. These get flagged by algorithms more often and carry a heavier revenue impact per denial.

Your Trusted Lab Billing Partner

Book Your Free Consultation

Book Consultation Today!

Book Consultation Today!